Alternate Health (OTCMKTS:AHGIF) vs. Standard BioTools (NASDAQ:LAB) Critical Contrast

Standard BioTools (NASDAQ:LAB – Get Free Report) and Alternate Health (OTCMKTS:AHGIF – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.

Insider & Institutional Ownership

53.7% of Standard BioTools shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Standard BioTools and Alternate Health’s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Standard BioTools and Alternate Health”s top-line revenue, earnings per share and valuation.

Alternate Health has lower revenue, but higher earnings than Standard BioTools.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Standard BioTools and Alternate Health, as reported by MarketBeat.

Standard BioTools currently has a consensus price target of $1.35, indicating a potential upside of 5.47%. Given Standard BioTools’ stronger consensus rating and higher possible upside, equities analysts plainly believe Standard BioTools is more favorable than Alternate Health.

Summary

Standard BioTools beats Alternate Health on 5 of the 8 factors compared between the two stocks.

About Standard BioTools

(Get Free Report)

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

About Alternate Health

(Get Free Report)

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.